genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2008
Asuragen
News
Applied Biosystems and Asuragen to Help C-Path Develop Drug Toxicity Screening Assays
News
Asuragen Launches Company Focused on miRNAs
News
Asuragen Accesses Xenomic’s NPM1 Technology for Diagnostic Development
News
Asuragen to Develop Cancer Pharmacogenomic Assay for Merck
Insights
miRNA Becoming a Research Priority
News
Asuragen Licenses Yale miRNA Inventions with Potential in Lung Cancer
Insights
Multidisciplinary Approach to RNAi
News
Focus Diagnostics to Employ Asuragen’s Technology to Improve Diagnostics
News
Agendia Gains Rights to Asuragen’s RNARetain
1
2
Page 2 of 2
Scroll Up
Scroll Up
